COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 24: Articles 231-240  | Next

Pediatric Long COVID Is Characterized by Myeloid CCR6 Suppression and Immune Dysregulation
Izquierdo-Pujol, J., Pedreno-Lopez, N., Pidkova, T., Nevot, M., Urrea, V., Laguia, F., Munoz-Lopez, F., Dalmau, J., Gonzalez-Aumatell, A., Carreras-Abad, C., Mendez, M., Rodrigo, C., Massanella, M., Blanco, J., Carrillo, J., Trinite, B., Martinez-Picado, J., Moron-Lopez, S.
10.1101/2025.08.22.671713 — Posted: 2025-08-22
Wastewater-based Surveillance as a tool for monitoring and estimating COVID-19 incidence and trends: Insights from Germany, 2022-2024
Abunijela, S., Pütz, P., Greiner, T., Lehfeld, A.-S., Schattschneider, A., Buchholz, U., Schumacher, J.
10.1101/2025.08.19.25333953 — Posted: 2025-08-21
Quantifying contributing factors for hospitalization inequalities: influenza and COVID-19, England, 2023 to 2024
Scott, M., Browning, L., Roberts, T., Richardson, Z. A.
10.1101/2025.08.14.25333430 — Posted: 2025-08-21
The experience of conducting non-pandemic research during the COVID-19 pandemic: a case study
June, M. J., Otiti, M. I., Mbanda, N. O., Miruye, P. O., Allen, S. J., OMathuna, D.
10.1101/2025.08.15.25333770 — Posted: 2025-08-20
Orthorhombic coronavirus main protease crystals provide a higher success rate in fragment screening
Barthel, T., Wollenhaupt, J., Benz, L. S., Reinke, P. Y. A., Zhang, L., Oelker, M., Lennartz, F., Taberman, H., Mueller, U., Meents, A., Hilgenfeld, R., Weiss, M. S.
10.1101/2025.08.20.671191 — Posted: 2025-08-20
Counterfactual evaluation of elementary and secondary school policies in the COVID-19 pandemic
Canfora, B., Escosio, R. A., Boldea, O., Nunes, A., Rozhnova, G.
10.1101/2025.08.17.25333861 — Posted: 2025-08-19
Effect of COVID-19 lockdown on sleep quality, sleep duration, and acute stress in Indian young adults
Soni, R., Gupta, I., Qureshi, S., Akhtar, N.
10.1101/2025.08.15.25333638 — Posted: 2025-08-19
Monoclonal Antibodies from COVID-19 Convalescent Patients Target Cryptic Epitopes for Universal SARS-CoV-2 Neutralization
Harit, A., Mor, M., Yefet, R., Izhaki-Tavor, L. S., Gal-Tanamy, M., Freund, N., Dessau, M.
10.1101/2025.08.17.670707 — Posted: 2025-08-19
Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants
Dadonaite, B., Harari, S., Larsen, B. B., Kampman, L., Harteloo, A., Elias-Warren, A., Chu, H. Y., Bloom, J. D.
10.1101/2025.08.18.671001 — Posted: 2025-08-19
Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice
Fan, C., Cohen, A. A., Dam, K.-M. A., Rorick, A. V., Priso Fils, A.-C. I., Yang, Z., Gnanapragasam, P. N., Segovia, L. N., Huey-Tubman, K. E., Moon, W. J., Lin, P. J., Bjorkman, P. J., Hoffmann, M. A.
10.1101/2025.08.18.670983 — Posted: 2025-08-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).